Annual report pursuant to Section 13 and 15(d)

Balance Sheets

v3.19.1
Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 11,439 $ 11,469
Short-term investments 32,718 32,424
Prepaid expenses and other current assets 7,251 1,067
Restricted cash 55 0
Total current assets 51,463 44,960
Other assets 812 572
Deferred offering costs 106 314
Restricted cash 273 0
Property and equipment 516 4
Total assets 53,170 45,850
Current liabilities:    
Accounts payable 3,653 3,833
Accrued expenses 2,103 1,705
Deferred revenue, current portion 121 257
Loan payable, current portion 0 4,349
Total current liabilities 5,877 10,144
Deferred revenue, non-current 0 121
Warrant liabilities 986 3,872
Loan payable expected to be refinanced (see Note 7) 15,082 10,303
Total liabilities 21,945 24,440
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.001 par value, authorized 5,000,000 shares as of December 31, 2018 and December 31, 2017; 0 shares issued and outstanding as of December 31, 2018 and December 31, 2017 0 0
Common stock, $0.001 par value, authorized 125,000,000 shares as of December 31, 2018 and December 31, 2017; 47,971,989 and 28,971,651 shares issued and outstanding as of December 31, 2018, and December 31, 2017, respectively 48 29
Additional paid-in capital 248,895 226,631
Accumulated deficit (217,718) (205,250)
Total stockholders’ equity 31,225 21,410
Total liabilities and stockholders’ equity $ 53,170 $ 45,850